Octopus Biosafety (FRA:OCR) Accounts Receivable: €0.03 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OCR Octopus Biosafety FRA:OCR
7 GF Score
Price €0.13
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Accounts Receivable?

Octopus Biosafety FRA:OCR +23.15% 7 Accounts Receivable is €0.03 Mil as of Dec. 2024. GuruFocus rates FRA:OCR with a GF Score™ of 7/100. The stock has 2 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Octopus Biosafety's accounts receivables for the quarter that ended in Dec. 2024 was €0.03 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Octopus Biosafety's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 87.74.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Octopus Biosafety's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was €-0.07.


Octopus Biosafety Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Octopus Biosafety's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.025/0.052*91
=87.74

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Octopus Biosafety's accounts receivable are only considered to be worth 75% of book value:

Octopus Biosafety's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.023+0.75 * 0.025+0.5 * 0-1.145
-0-0)/14.784
=-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Octopus Biosafety Accounts Receivable Related Terms


Octopus Biosafety Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Accounts Receivable Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.06 0.07 0.06 0.03

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.06 0.07 0.06 0.03
FRA:OCR
7GF Score
Octopus Biosafety FRA:OCR
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of €0.03 Mil mean?
Octopus Biosafety (FRA:OCR) has a Accounts Receivable of €0.03 Mil as of Dec. 2024. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Accounts Receivable too high?
Octopus Biosafety's current Accounts Receivable is €0.03 Mil. Overall, Octopus Biosafety has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Accounts Receivable compare to DELL and ANET?
Octopus Biosafety's Accounts Receivable of €0.03 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Hardware company?
A good Accounts Receivable depends on the Hardware industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Accounts Receivable is €0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (FRA:OCR) has a current Accounts Receivable of €0.03 Mil. The current Accounts Receivable is €0.03 Mil. Octopus Biosafety's overall GF Score™ is 7/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Octopus Biosafety (FRA:OCR), the current Accounts Receivable is €0.03 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
7GF Score

Get the complete analysis for FRA:OCR

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price